Pathological Findings of Non-Bullous Pemphigoid and Differences from Bullous Pemphigoid
Non-bullous pemphigoid (NBP) is a distinct variant of bullous pemphigoid (BP) characterized by the absence of blisters but with identical immunopathological findings, including linear deposits of IgG and/or C3 along the dermoepidermal junction. 1, 2
Pathological Findings of Non-Bullous Pemphigoid
Histopathology
- Light microscopy findings:
Immunopathology
Direct immunofluorescence (DIF):
Indirect immunofluorescence (IIF):
Immunoelectron microscopy:
- Deposits localized within the lamina lucida and over hemidesmosomal plaques 3
Serological findings:
Differences Between Non-Bullous and Bullous Pemphigoid
Clinical Presentation
Non-bullous pemphigoid:
- No blisters or vesicles 3, 2
- Presents with pruritic papules/nodules (37%) or pruritus without primary skin lesions (22%) 2
- Erythematous, urticarial plaques (52.3%) 4
- Excoriations, prurigo-like lesions, eczematous lesions 1, 5
- May precede bullous form by weeks, months, or years 1
- Only 9.8-23% of patients develop blisters during follow-up 2, 6
Bullous pemphigoid:
Histopathology
Non-bullous pemphigoid:
Bullous pemphigoid:
Diagnostic Challenges
Non-bullous pemphigoid:
Bullous pemphigoid:
- More readily diagnosed due to characteristic blisters 1
Laboratory Markers
- Non-bullous pemphigoid:
Clinical Implications
- Both forms affect predominantly elderly patients (>70 years) 1, 5
- Both have similar mortality rates (8.6-fold increased all-cause mortality risk in NBP) 2
- Both respond to similar treatments, though treatment intensity may differ 5
- Both are associated with neurological conditions such as dementia, Parkinson's disease, and cerebrovascular disease 5
Diagnostic Algorithm for Suspected Non-Bullous Pemphigoid
- Consider in elderly patients with persistent unexplained pruritus, especially with urticarial or eczematous lesions 5, 4
- Perform skin biopsy for histopathology (may show nonspecific findings) 2
- Obtain perilesional skin biopsy for DIF (essential for diagnosis) 1
- Perform serum testing with IIF on salt-split skin and ELISA for anti-BP180 and anti-BP230 antibodies 1, 5
- Monitor for potential development of blisters, especially in patients with positive IIF and BP180 immunoblot 2
Understanding these differences is crucial for early diagnosis and appropriate management of non-bullous pemphigoid, which is often underdiagnosed due to its atypical presentation.